1. Rabert B Marcial. V. Kaplan & Sadock's Comprehensive TextBook of Psychiatry.11th ed.Wolters Kluwer; 2025. P.12477.

2. Sadock BJ, Sadock VA. Synopsis Of Psychiatry.12th ed. Philadelphia: Lippincott Williams & Wilkins; 2022. p. 206.

3. Dulcan MK, editor. Dulcan's textbook of child and adolescent psychiatry. American Psychiatric Pub; 2021 Oct 18. doi:10.1176/appi.books.9781615374809 PMid:33818599 PMCid:PMC8022269

4. Assarian F, Biqam H, Asqarnejad A. An epidemiological study of obsessivecompulsive disorder among high school students and its relationship with religious attitudes. Arch Iran Med. 2006;9(2):104-7

5. Dold M, Aigner M, Lanzenberger R, Kasper S. Efficacy of antipsychotic augmentation therapy in treatment resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomised, placebo-controlled trials. Fortschr Neurol Psychiatr. 2011; 79(8): 453-66. doi:10.1055/s-0031-1273397 PMid:21809258

6. Afshar H, Roohafza H, Mohammad-Beigi H, Haghighi M, Jahangard L, Shokouh P, et al. N-Acetylcysteine Add-On Treatment in Refractory Obsessive-Compulsive Disorder A Randomized, Double-Blind, Placebo-Controlled Trial. J Clin Psychopharmacol 2012; 32: 797-803. doi:10.1097/JCP.0b013e318272677d PMid:23131885

7. Carey PD, Lochner C, Kidd M, Ameringend MV, Steinc DJ, Denys D. Quetiapine augmentation of serotonin reuptake inhibitors in treatment-refractory obsessive-compulsive disorder: is response to treatment predictable? Int Clin Psychopharmacol. 2012; 27(6): 321-5. doi:10.1097/YIC.0b013e3283576881 PMid:22859064

8. Ardic UA, Ercan ES, Kutlu A, Yuce D, Ipci M, Inci SB. Successful Treatment Response with Aripiprazole Augmentation of SSRIs in Refractory Obsessive-Compulsive Disorder in Childhood. Child Psychiatry Hum Dev. 2016: 1-6.

9. Ercan ES, Ardic UA, Ercan E, Yuce D, Durak S. A promising preliminary study of aripiprazole for treatment-resistant childhood obsessive-compulsive disorder. J Child Adolesc Psychopharmacol. 2015; 25(7): 580-4. doi:10.1089/cap.2014.0128 PMid:26375768

10. Selvi Y, Atli A, Aydin A, Besiroglu L, Ozdemir P, Ozdemir O. The comparison of aripiprazole and risperidone augmentation in selective serotonin reuptake inhibitor refractory obsessive compulsive disorder: a single blind, randomised study. Human Psychopharmacology: Clin Experimental. 2011; 26(1): 51-7. doi:10.1002/hup.1169 PMid:21308781

11. Masi G, Pfanner C, Millepiedi S, Berloffa S. Aripiprazole augmentation in 39adolescents with medication-resistant obsessive-compulsive disorder. J Clin Psychopharmacol. 2010; 30(6): 688-93 doi:10.1097/JCP.0b013e3181fab7b1 PMid:21105283

12. Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, et al. Children's Yale-Brown obsessive compulsive scale: reliability and validity. J Am Academy Child Adolescent Psychiatry. 1997; 36(6): 844-52. doi:10.1097/00004583-199706000-00023 PMid:9183141

13. Gallant J, Storch EA, Merlo LJ, Ricketts ED, Geffken GR, Goodman WK, et al. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-symptom checklist. J Anxiety Disord. 2008; 22(8):1369-76. doi:10.1016/j.janxdis.2008.01.017 PMid:18329843

14. Mohsenabadi H, Shabani MJ, Assarian F, Zanjani Z. Psychometric Properties of the Child and Adolescent Mindfulness Measure: A Psychological Measure of Mindfulness in Youth. 2020; 14(1):e79986. doi:10.5812/ijpbs.79986

15. National Institute for Health and Clinical Excellence: guidance. Obsessive-compulsive disorder: core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder, 2006.

16. Connor KM, Payne VM, Gadde KM, Zhang W, Davidson JR, Connor KM. The use of aripiprazole in obsessive- compulsive disorder: preliminary observations in 8 patients. J Clin Psychiatry. 2005; 66(1): 49-51 doi:10.4088/JCP.v66n0107 PMid:15669888

17. Barkoulias V, Stockings E. Asystematic review of the use of risperidone paliperidone and aripiprazole as augmentating agents for obsessive compulsive disorder. Expert Opin Pharmacother. 2019; 20(1): 47-53. doi:10.1080/14656566.2018.1540590 PMid:30360669

18. Storch EA, Lehmkuhl H, Geffken GR, Touchton A, Murphy TK. Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder. Depress Anxiety. 2008; 25(2): 172-4. doi:10.1002/da.20303 PMid:17340610

19. Sarkar R, Klein J, Kruger S. Aripiprazole augmentation in treatment-refractory obsessive-compulsive disorder. Psychopharmacology (Berl) 2008; 197(4): 687-8. doi:10.1007/s00213-008-1091-1 PMid:18264798

20. Ercan ES, Ardic UA, Ercan E, Yuce D, Durak S. A promising preliminary study of aripiprazole for treatment-resistant childhood obsessive-compulsive disorder. J Child Adolesc Psychopharmacol. 2015; 25(7): 580-4. doi:10.1089/cap.2014.0128 PMid:26375768

21. Yaylaci F, Erkuran HO, Eyuboglu M. Early-term Aripiprazole Augmentation and Clinical Efficacy in Treatment of Pediatric OCD: A Case Series of Six Adolescents. Psychiatry Behav Sci. 2019; 9(4): 179.doi:10.5455/PBS.20190221072254

22. Efficacy in Treatment of Pediatric OCD: A Case Series of Six Adolescents. Psychiatry Behav Sci. 2019; 9(4): 179-87.